-- WELL Health Technologies (WELL.TO) Thursday after trade reported adjusted first-quarter earnings and revenue that both beat estimates.
Adjusted net income, excluding most one-time items, more than doubled to $15.5 million, or $0.06 per share, from $7.5 million, or $0.03, in the prior year period. The result beat the consensus analyst estimate of $0.05 per share, according to FactSet.
Revenues surged 25% to $368.3 million, beating the $366.98 million forecast. The increase was driven by organic growth, acquisitions and the inclusion of Healwell results in WELL's consolidated financial reporting, a statement said.
Total patient visits rose 17% year-over-year to 1.9 million. At the end of the first quarter, WELL reported 253 clinics across Canada, including primary care, diagnostics, allied health, specialty and executive health clinics.
WELL maintained its guidance for annual revenue of between $1.55 billion to $1.65 billion with adjusted EBITDA in the range of $175 million to $185 million.
"We are very pleased to report a strong start to 2026, with solid first quarter performance that saw our revenue run rate approach the $1.5 billion per year mark. Our Canadian clinics business continued to be a key driver of growth, achieving a revenue run rate of over half a billion dollars per year while delivering 30% year-over-year revenue growth, including 13% organic growth," said chief executive Hamed Shahbazi.
Well Health shares closed up $0.03 to $4.37 on the Toronto Stock Exchange.